| Financial Year |
March 31 2023 |
| Monetary Funds |
346,313,047.79 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
11,646,000.00 |
| Accounts Receivable |
410,464,317.83 |
| Advances to Suppliers |
63,298,308.31 |
| Other Receivables |
44,213,097.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,818,026,799.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,910,436.96 |
| Total Current Assets |
2,702,424,638.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
824,354.91 |
| Long-term Equity Investment |
72,595,372.21 |
| Investment Properties |
215,365,858.69 |
| Fixed Assetes |
138,934,859.29 |
| Under-construction Projects |
2,071,155.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,149,286.95 |
| R&D expenses |
-- |
| Goodwill |
18,875,678.92 |
| Long-Term Deferred and Prepaid Expenses |
31,628,683.72 |
| Deferred Income Tax Assets |
18,263,335.77 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
646,458,805.25 |
| Total Assets |
3,348,883,444.04 |
| Short-Term Loans |
296,696,020.48 |
| Trading Financial liabilities |
38,985,034.10 |
| Notes Payable |
-- |
| Accounts Payable |
426,891,517.42 |
| Accounts Received In Advance |
701,515.86 |
| Employee Compensation Payable |
4,718,250.86 |
| Taxes Payable |
19,001,222.07 |
| Interest Payable |
-- |
| Dividend Payable |
1,035,734.28 |
| Other payables |
612,219,312.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
68,027,478.22 |
| Other Current Liabilities |
11,892,277.26 |
| Sub-Total of Current Liabilities |
1,622,751,173.40 |
| Long-term Loans |
544,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
176,668,961.69 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,692,444.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
760,070,267.66 |
| Total Liabilities |
2,382,821,441.06 |
| Paid-In Capital(Or Share Stock) |
351,764,064.00 |
| Capital Surplus |
60,763,161.14 |
| Surplus Reserve |
78,236,837.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
404,853,579.53 |
| Minority Stockholder's Interest |
59,168,273.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
906,893,729.74 |
| Owner's Equity（Stockholder's Equity） |
966,062,002.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,348,883,444.04 |
